We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Panel Smacks Down Cancer Treatment; Lack of Safety, Efficacy Data at Issue
Panel Smacks Down Cancer Treatment; Lack of Safety, Efficacy Data at Issue
Concerns about safety and efficacy data from a U.S. clinical trial, insufficient patient follow-up and the questionable culling of data from a European patient registry sank the Ablatherm-HIFU system for treatment of low-risk prostate cancer during a Wednesday FDA advisory panel meeting.